Avadel CNS Pharmaceuticals, LLC
$2.1M 9,568 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Recor Medical Inc
Recor Medical Inc reported $2,051,900.84 across General Payments, Research, and Ownership to 2,012 physicians and teaching hospitals across 2,486 transactions.
- $2.1M Top quartile payer
- All-tracks total
- 2,486 Top quartile volume
- Transactions
- 2,012 Top quartile reach
- Recipients
- #443
- of 1,925 companies
Recor Medical Inc reported $2,051,900.84 across all CMS Open Payments tracks (General + Research + Ownership) to 2,012 physicians and teaching hospitals in Program Year 2024 - ranking #443 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $244,107.80, averaging $1.0K per recipient.
How Recor Medical Inc's $2.1M all-tracks total breaks down
Recor Medical Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
33/100
Total payments
F
29/100
Transaction volume
F
28/100
Physician reach
F
25/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer recor-medical-inc Recor Medical Inc
$2.1M · #443/1,925 · 0.0% industry · PY2024
- TOT $2.1M
- RANK #443
- SHARE 0.0%
- TXN 2,486
- RCP 2,012
- CAT 4
- GEN $244.1K
- TOP1 30.7%
- PY 2024
Volume peers
Nearest volume peer: Avadel CNS Pharmaceuticals, LLC ($2.1M)
Recor Medical Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Recor Medical Inc
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Recor Medical Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
The 4-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Food and Beverage" at $99.6K, accounting for 40.8% of this company's General Payments and 1,942 transactions.
General Payment Breakdown by Type
Across 4 types of general payments, Recor Medical Inc's largest category was "Food and Beverage" at $99.6K - 40.8% of General Payments.
Recor Medical Inc reports 4 general-payment categories - the top three are Food and Beverage (40.8%), Grant (30.7%), and Consulting Fee (19.1%). The remaining 1 category make up 9.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Recor Medical Inc divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $99.6K | 1,942 | 40.8% |
| Grant | $75.0K | 1 | 30.7% |
| Consulting Fee | $46.6K | 32 | 19.1% |
| Travel and Lodging | $22.8K | 37 | 9.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $108,620.21 (44.5%) of $244,107.80 in this company's General Payments records across 1,335 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Recor Medical Inc
The five named recipients with the highest reported General Payments from this company
- 1
Hospital Of The Univ Of Penna
$75,000.00 across 1 reported transactions
- 2
Taisei Kobayashi
$9,288.27 across 3 reported transactions
- 3
Wayne Batchelor
$8,923.93 across 6 reported transactions
- 4
Thomas Todoran
$8,181.15 across 11 reported transactions
- 5
Michael Bloch
$7,226.86 across 8 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Recor Medical Inc ranks #443 of 1,925 by total payments (top 23% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,019 of 1,838 by HHI (bottom 45% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Hoffmann-La Roche Limited : $185.6K total payments, HHI 1042
- NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd. : $273.1K total payments, HHI 1042
- PolyMedics Innovations Inc. : $62.1K total payments, HHI 1036
- Qiagen, LLC : $659.8K total payments, HHI 1034
- Seigla Medical, Inc. : $1.1K total payments, HHI 1032
- Zimmer Biomet Holdings, Inc. : $83.9M total payments, HHI 1031
- Recor Medical Inc (this company) : $244.1K total payments, HHI 1026
- Bioprotect Medical, Inc. : $136.5K total payments, HHI 1025
- I/O Urology Corp. : $2.1K total payments, HHI 1025
- Cardinal Health 200 LLC : $63.8K total payments, HHI 1024
- Genesys Orthopedics Systems, L.L.C. : $837.2K total payments, HHI 1023
- Procyrion, Inc. : $53.4K total payments, HHI 1019
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Recor Medical Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Recor Medical Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Recor Medical Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
TELA Bio, Inc.
$2.1M 7,569 recipients
Compare payment profiles
Musculoskeletal Transplant Foundation Inc.
$2.1M 3,503 recipients
Compare payment profiles
Omnia Medical, LLC
$2.0M 110 recipients
Compare payment profiles
Immunocore Limited
$2.0M 1,028 recipients
Compare payment profiles
Roche Diagnostics Corporation
$2.0M 900 recipients
Compare payment profiles
Put this to use
Recor Medical Inc ranks #443 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See where Recor Medical Inc sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Recor Medical Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.